Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.19% higher to $68.20 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.16% to 3,971.27 and Dow Jones Industrial Average falling 0.12% to 32,394.25. This was the stock's third consecutive day of gains. Bristol Myers Squibb Co. closed $13.24 below its 52-week high ($81.44), which the company reached on December 1st.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.97% to $151.82, Pfizer Inc. (PFE) fell 0.57% to $39.99, and Abbott Laboratories (ABT) fell 1.37% to $97.11. Trading volume (4.7 M) remained 3.6 million below its 50-day average volume of 8.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 28, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 28, 2023 16:42 ET (20:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.